Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Document › Details

Affimed N.V.. (3/15/18). "Press Release: Affimed to Present Data on AFM24 at AACR Annual Meeting 2018". Heidelberg.

Region Region Chicago, IL
  Country United States (USA)
Organisations Organisation Affimed N.V. (Nasdaq: AFMD)
  Group Affimed (Group)
  Organisation 2 American Association for Cancer Research (AACR)
Products Product AFM24 (EGFRwt/CD16A TandAb, Affimed)
  Product 2 AACR Annual Meeting 2018 Chicago
Person Person Ammon (formerly Alexandru), Anca (Ammon Communications 202103 before MorphoSys + Affimed + MacDougall European Office)
     


Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today the presentation of preclinical data for the Company’s AFM24 program at the AACR Annual Meeting 2018 in Chicago, IL.


Poster Presentation

Abstract: Pharmacokinetics and in vitro/in vivo characterization of high-affinity bispecific EGFR/CD16A NK cell engagers for the treatment of EGFR-expressing tumors (#2786)

Session: PO.IM02.11 - Therapeutic Antibodies, Including Engineered Antibodies 2

Date and Time: Monday, April 16, 2018 1:00 PM - 5:00 PM (CT)

Location: McCormick Place South, Exhibit Hall A, Poster Section 34/Board 19, Chicago, IL

Full abstract of the presentation can be accessed on the AACR website at www.aacr.org


About Affimed N.V.

Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK and T cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases. For more information, please visit www.affimed.com.


Contact:

Anca Alexandru, Head of Communications, EU IR Phone: +49 6221 64793341 E-Mail: a.alexandru@affimed.com, IR@affimed.com

   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Affimed (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top